Table 4.
Ratio of predicted to observed risks of cardiovascular disease event at 10 years across tenths of estimated risks
Tenth* | QRISK | Framingham | ASSIGN | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Predicted risk (%) | Observed risk (%) | Ratio | Predicted risk (%) | Observed risk (%) | Ratio | Predicted risk (%) | Observed risk (%) | Ratio | |||
Women: | |||||||||||
First | 0.71 | 0.44 | 1.61 | 0.59 | 0.53 | 1.12 | 1.31 | 0.34 | 3.81 | ||
Second | 1.06 | 0.95 | 1.12 | 1.17 | 0.96 | 1.22 | 1.83 | 0.91 | 2.00 | ||
Third | 1.49 | 1.45 | 1.03 | 1.95 | 1.59 | 1.22 | 2.41 | 1.49 | 1.61 | ||
Fourth | 2.11 | 2.11 | 1 | 3.02 | 2.19 | 1.38 | 3.18 | 2.14 | 1.48 | ||
Fifth | 2.97 | 3.06 | 0.97 | 4.41 | 3.02 | 1.46 | 4.23 | 3.08 | 1.37 | ||
Sixth | 4.22 | 4.5 | 0.94 | 6.15 | 4.63 | 1.33 | 5.76 | 4.17 | 1.38 | ||
Seventh | 6.06 | 6.16 | 0.99 | 8.21 | 6.97 | 1.18 | 8.05 | 6.60 | 1.22 | ||
Eighth | 8.9 | 9.65 | 0.92 | 10.76 | 10.29 | 1.05 | 11.61 | 9.79 | 1.19 | ||
Ninth | 13.36 | 13.95 | 0.96 | 14.15 | 14.63 | 0.97 | 17.28 | 13.86 | 1.25 | ||
Tenth | 22.52 | 20.19 | 1.12 | 22.47 | 16.86 | 1.33 | 29.29 | 19.35 | 1.51 | ||
Overall | 6.34 | 6.25 | 1.02 | 7.28 | 6.16 | 1.18 | 8.49 | 6.17 | 1.38 | ||
Men: | |||||||||||
First | 1.64 | 0.93 | 1.77 | 2.86 | 1.03 | 2.79 | 3.37 | 0.92 | 3.65 | ||
Second | 2.24 | 1.6 | 1.39 | 4.19 | 1.73 | 2.43 | 4.36 | 1.63 | 2.68 | ||
Third | 2.92 | 2.6 | 1.12 | 5.54 | 2.53 | 2.19 | 5.31 | 2.56 | 2.07 | ||
Fourth | 3.81 | 3.86 | 0.99 | 7.04 | 3.71 | 1.90 | 6.43 | 3.39 | 1.90 | ||
Fifth | 5 | 4.86 | 1.03 | 8.86 | 5.43 | 1.63 | 7.83 | 5.22 | 1.50 | ||
Sixth | 6.61 | 6.67 | 0.99 | 11.13 | 7.38 | 1.51 | 9.65 | 7.16 | 1.35 | ||
Seventh | 8.88 | 9.88 | 0.9 | 14.00 | 10.11 | 1.38 | 12.16 | 10.19 | 1.19 | ||
Eighth | 12.24 | 14.24 | 0.86 | 17.78 | 13.90 | 1.28 | 15.76 | 13.97 | 1.13 | ||
Ninth | 17.4 | 18.46 | 0.94 | 23.19 | 19.05 | 1.22 | 21.30 | 18.79 | 1.13 | ||
Tenth | 27.86 | 25.72 | 1.08 | 35.24 | 23.42 | 1.51 | 33.34 | 24.49 | 1.36 | ||
Overall | 8.86 | 8.88 | 1.00 | 12.96 | 8.81 | 1.47 | 11.95 | 8.83 | 1.35 | ||
All patients | 7.59 | 7.56 | 1.004 | 10.10 | 7.48 | 1.35 | 10.21 | 7.49 | 1.36 |
Comparison between QRISK, Framingham, and ASSIGN in validation cohort in patients aged 35-74.
*First tenth is lowest tenth of risk.